Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine

Research output: Contribution to journalArticle

143 Citations (Scopus)

Abstract

OBJECTIVE: To determine if the incidence of empyema among children in the United States has changed since the introduction of the pneumococcal conjugate vaccine in 2000. METHODS: We used the nationally representative Kids' Inpatient Database to estimate the annual total number of hospitalizations of children ≤18 years of age that were associated with empyema in 1997, 2000, 2003, and 2006. Using US Census data, estimated counts were converted into annual incidence rates per 100 000 children. Incidence rates were compared between 1997 and later years to determine the impact of pneumococcal conjugate vaccine on hospitalization rates. RESULTS: During 2006, an estimated total of 2898 (95% confidence interval [CI]: 2532-3264) hospitalizations of children ≤18 years of age in the United States were associated with empyema. The empyema-associated hospitalization rate was estimated at 3.7 (95% CI: 3.3-4.2) per 100 000 children, an increase of almost 70% from the 1997 empyema hospitalization rate of 2.2 (95% CI: 1.9-2.5) per 100 000. The rate of complicated pneumonia (empyema, pleural effusion, or bacterial pneumonia requiring a chest tube or decortication) similarly increased 44%, to 5.5 (95% CI: 4.8-6.1) per 100 000. The rate of bacterial pneumonia decreased 13%, to 244.3 (95% CI: 231.1-257.5) per 100 000. The rate of invasive pneumococcal disease (pneumonia, sepsis, or meningitis caused by Streptococcus pneumoniae) decreased 50%, to 6.3 (95% CI: 5.7-6.9) per 100 000. CONCLUSIONS: Among children ≤18 years of age, the annual empyema-associated hospitalization rates increased almost 70% between 1997 and 2006, despite decreases in the bacterial pneumonia and invasive pneumococcal disease rates. Pneumococcal conjugate vaccine is not decreasing the incidence of empyema.

Original languageEnglish (US)
Pages (from-to)26-33
Number of pages8
JournalPediatrics
Volume125
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Conjugate Vaccines
Pneumococcal Vaccines
Empyema
Hospitalization
Confidence Intervals
Bacterial Pneumonia
Incidence
Pneumococcal Meningitis
Pneumococcal Pneumonia
Chest Tubes
Censuses
Pleural Effusion
Inpatients
Sepsis
Pneumonia
Databases

Keywords

  • Adolescent
  • Child
  • Empyema
  • Epidemiology
  • Heptavalent pneumococcal conjugate vaccine
  • Infant
  • Pneumococcal
  • Pneumococcal infections
  • Pneumonia
  • Preschool
  • Retrospective studies
  • United States

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. / Li, Su-Ting Terry; Tancredi, Daniel J.

In: Pediatrics, Vol. 125, No. 1, 01.2010, p. 26-33.

Research output: Contribution to journalArticle

@article{48079cee742b4b929bf1bb1b77822c2d,
title = "Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine",
abstract = "OBJECTIVE: To determine if the incidence of empyema among children in the United States has changed since the introduction of the pneumococcal conjugate vaccine in 2000. METHODS: We used the nationally representative Kids' Inpatient Database to estimate the annual total number of hospitalizations of children ≤18 years of age that were associated with empyema in 1997, 2000, 2003, and 2006. Using US Census data, estimated counts were converted into annual incidence rates per 100 000 children. Incidence rates were compared between 1997 and later years to determine the impact of pneumococcal conjugate vaccine on hospitalization rates. RESULTS: During 2006, an estimated total of 2898 (95{\%} confidence interval [CI]: 2532-3264) hospitalizations of children ≤18 years of age in the United States were associated with empyema. The empyema-associated hospitalization rate was estimated at 3.7 (95{\%} CI: 3.3-4.2) per 100 000 children, an increase of almost 70{\%} from the 1997 empyema hospitalization rate of 2.2 (95{\%} CI: 1.9-2.5) per 100 000. The rate of complicated pneumonia (empyema, pleural effusion, or bacterial pneumonia requiring a chest tube or decortication) similarly increased 44{\%}, to 5.5 (95{\%} CI: 4.8-6.1) per 100 000. The rate of bacterial pneumonia decreased 13{\%}, to 244.3 (95{\%} CI: 231.1-257.5) per 100 000. The rate of invasive pneumococcal disease (pneumonia, sepsis, or meningitis caused by Streptococcus pneumoniae) decreased 50{\%}, to 6.3 (95{\%} CI: 5.7-6.9) per 100 000. CONCLUSIONS: Among children ≤18 years of age, the annual empyema-associated hospitalization rates increased almost 70{\%} between 1997 and 2006, despite decreases in the bacterial pneumonia and invasive pneumococcal disease rates. Pneumococcal conjugate vaccine is not decreasing the incidence of empyema.",
keywords = "Adolescent, Child, Empyema, Epidemiology, Heptavalent pneumococcal conjugate vaccine, Infant, Pneumococcal, Pneumococcal infections, Pneumonia, Preschool, Retrospective studies, United States",
author = "Li, {Su-Ting Terry} and Tancredi, {Daniel J}",
year = "2010",
month = "1",
doi = "10.1542/peds.2009-0184",
language = "English (US)",
volume = "125",
pages = "26--33",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "1",

}

TY - JOUR

T1 - Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine

AU - Li, Su-Ting Terry

AU - Tancredi, Daniel J

PY - 2010/1

Y1 - 2010/1

N2 - OBJECTIVE: To determine if the incidence of empyema among children in the United States has changed since the introduction of the pneumococcal conjugate vaccine in 2000. METHODS: We used the nationally representative Kids' Inpatient Database to estimate the annual total number of hospitalizations of children ≤18 years of age that were associated with empyema in 1997, 2000, 2003, and 2006. Using US Census data, estimated counts were converted into annual incidence rates per 100 000 children. Incidence rates were compared between 1997 and later years to determine the impact of pneumococcal conjugate vaccine on hospitalization rates. RESULTS: During 2006, an estimated total of 2898 (95% confidence interval [CI]: 2532-3264) hospitalizations of children ≤18 years of age in the United States were associated with empyema. The empyema-associated hospitalization rate was estimated at 3.7 (95% CI: 3.3-4.2) per 100 000 children, an increase of almost 70% from the 1997 empyema hospitalization rate of 2.2 (95% CI: 1.9-2.5) per 100 000. The rate of complicated pneumonia (empyema, pleural effusion, or bacterial pneumonia requiring a chest tube or decortication) similarly increased 44%, to 5.5 (95% CI: 4.8-6.1) per 100 000. The rate of bacterial pneumonia decreased 13%, to 244.3 (95% CI: 231.1-257.5) per 100 000. The rate of invasive pneumococcal disease (pneumonia, sepsis, or meningitis caused by Streptococcus pneumoniae) decreased 50%, to 6.3 (95% CI: 5.7-6.9) per 100 000. CONCLUSIONS: Among children ≤18 years of age, the annual empyema-associated hospitalization rates increased almost 70% between 1997 and 2006, despite decreases in the bacterial pneumonia and invasive pneumococcal disease rates. Pneumococcal conjugate vaccine is not decreasing the incidence of empyema.

AB - OBJECTIVE: To determine if the incidence of empyema among children in the United States has changed since the introduction of the pneumococcal conjugate vaccine in 2000. METHODS: We used the nationally representative Kids' Inpatient Database to estimate the annual total number of hospitalizations of children ≤18 years of age that were associated with empyema in 1997, 2000, 2003, and 2006. Using US Census data, estimated counts were converted into annual incidence rates per 100 000 children. Incidence rates were compared between 1997 and later years to determine the impact of pneumococcal conjugate vaccine on hospitalization rates. RESULTS: During 2006, an estimated total of 2898 (95% confidence interval [CI]: 2532-3264) hospitalizations of children ≤18 years of age in the United States were associated with empyema. The empyema-associated hospitalization rate was estimated at 3.7 (95% CI: 3.3-4.2) per 100 000 children, an increase of almost 70% from the 1997 empyema hospitalization rate of 2.2 (95% CI: 1.9-2.5) per 100 000. The rate of complicated pneumonia (empyema, pleural effusion, or bacterial pneumonia requiring a chest tube or decortication) similarly increased 44%, to 5.5 (95% CI: 4.8-6.1) per 100 000. The rate of bacterial pneumonia decreased 13%, to 244.3 (95% CI: 231.1-257.5) per 100 000. The rate of invasive pneumococcal disease (pneumonia, sepsis, or meningitis caused by Streptococcus pneumoniae) decreased 50%, to 6.3 (95% CI: 5.7-6.9) per 100 000. CONCLUSIONS: Among children ≤18 years of age, the annual empyema-associated hospitalization rates increased almost 70% between 1997 and 2006, despite decreases in the bacterial pneumonia and invasive pneumococcal disease rates. Pneumococcal conjugate vaccine is not decreasing the incidence of empyema.

KW - Adolescent

KW - Child

KW - Empyema

KW - Epidemiology

KW - Heptavalent pneumococcal conjugate vaccine

KW - Infant

KW - Pneumococcal

KW - Pneumococcal infections

KW - Pneumonia

KW - Preschool

KW - Retrospective studies

KW - United States

UR - http://www.scopus.com/inward/record.url?scp=74049156843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74049156843&partnerID=8YFLogxK

U2 - 10.1542/peds.2009-0184

DO - 10.1542/peds.2009-0184

M3 - Article

C2 - 19948570

AN - SCOPUS:74049156843

VL - 125

SP - 26

EP - 33

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 1

ER -